These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28933284)

  • 1. Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose.
    Huang Z; Yao Q; Wei S; Chen J; Gao Y
    Curr Med Chem; 2019; 26(8):1351-1365. PubMed ID: 28933284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
    Kojima R; Aubel D; Fussenegger M
    Curr Opin Chem Biol; 2015 Oct; 28():29-38. PubMed ID: 26056952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 5. Special Issue "Recent Advances in Precision Nanomedicine for Cancer".
    Brignole C; Pastorino F
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme-Instructed Self-Assembly (EISA) and Hydrogelation of Peptides.
    Gao J; Zhan J; Yang Z
    Adv Mater; 2020 Jan; 32(3):e1805798. PubMed ID: 31018025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-Instructed Supramolecular Self-Assembly with Anticancer Activity.
    Yao Q; Huang Z; Liu D; Chen J; Gao Y
    Adv Mater; 2019 Nov; 31(45):e1804814. PubMed ID: 30444545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric Nanoreactors as Emerging Nanoplatforms for Cancer Precise Nanomedicine.
    Li X; Zhao X; Lv R; Hao L; Huo F; Yao X
    Macromol Biosci; 2021 Jun; 21(6):e2000424. PubMed ID: 33811465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-instructed self-assembly (EISA) assists the self-assembly and hydrogelation of hydrophobic peptides.
    Li X; Wang Y; Zhang Y; Yang Z; Gao J; Shi Y
    J Mater Chem B; 2022 May; 10(17):3242-3247. PubMed ID: 35437539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications.
    Wang J; Wang X; Yang K; Hu S; Wang W
    Biosensors (Basel); 2022 Aug; 12(9):. PubMed ID: 36140068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanohybrids - cancer theranostics for tiny tumor clusters.
    Dhandapani R; Sethuraman S; Subramanian A
    J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable Construction of Peptide-Based Materials in Living Subjects: From Modular Design and Morphological Control to Theranostics.
    Li LL; Qiao ZY; Wang L; Wang H
    Adv Mater; 2019 Nov; 31(45):e1804971. PubMed ID: 30450607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
    Opoku-Damoah Y; Wang R; Zhou J; Ding Y
    Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular cancer nanotheranostics.
    Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
    Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
    Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
    Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing Cancer Chemotherapeutic Toxicity, Resistance, and Heterogeneity: Novel Theranostic Use of DNA-Encoded Small Molecule Libraries.
    Kolodny G; Li X; Balk S
    Bioessays; 2018 Oct; 40(10):e1800057. PubMed ID: 30101540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.